[Multiple myeloma with two serum M components (IgG-lambda, IgA-kappa) and two Bence Jones proteins (lambda, kappa)--evidence for two distinct monoclonal cell populations and effects of chemotherapy and plasmapheresis].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001536:Bence Jones Protein / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007145:Immunoglobulin kappa-Chains / Q000032:analysis; D007136:Immunoglobulins; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology* / Q000628:therapy; D010956:Plasmapheresis
D001798:Blood Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains; D007136:Immunoglobulins; C009823:M-proteins (Myeloma); D001536:Bence Jones Protein